Huahui Health
Clinical trials sponsored by Huahui Health, explained in plain language.
-
New hope for liver cancer patients: experimental drug HH-009 enters trial
Disease control Not yet recruitingThis study tests an experimental drug called HH-009 in about 30 people with advanced liver cancer that has gotten worse after other treatments. Participants will receive one of two doses of HH-009 every three weeks. The goal is to see if the drug can slow cancer growth and how sa…
Phase: PHASE1, PHASE2 • Sponsor: Huahui Health • Aim: Disease control
Last updated May 26, 2026 06:37 UTC
-
New hope for hepatitis b? drug trial targets virus levels
Disease control Not yet recruitingThis study tests a new drug, HH-006, in 45 adults with chronic hepatitis B. Participants take the drug for 48 weeks to see if it lowers hepatitis B surface antigen (HBsAg) levels. The goal is to control the virus, not cure it, as ongoing management may still be needed.
Phase: PHASE2 • Sponsor: Huahui Health • Aim: Disease control
Last updated May 26, 2026 06:24 UTC